AMGN
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F2662177&ei=kXKaUoDPOcu40AHPMA&usg=AFQjCNET6M7TwYBCypPoe9KciiAkw0UZ6Q
Amgen Inc To Pay $762 Million In Marketing Case-Reuters
Tuesday, 18 Dec 2012 01:14pm EST
Reuters reported that Amgen Inc in a New York federal court for improper marketing practices involving its once top-selling Aranesp anemia drug, and prosecutors said the Company has agreed to pay $762 million in a civil settlement and criminal fines. Federal prosecutors said in court that the Company had agreed to pay $612 million in a civil settlement, a $14 million criminal forfeiture payment, and a $136 million criminal fine.Â 
